iShares MSCI USA Value Factor ETF (BATS:VLUE – Get Free Report)’s stock price hit a new 52-week high on Monday . The stock traded as high as $115.88 and last traded at $115.39, with a volume of 839167 shares. The stock had previously closed at $114.13.
iShares MSCI USA Value Factor ETF Trading Down 0.4 %
The firm’s fifty day moving average price is $110.24 and its 200-day moving average price is $106.46. The firm has a market cap of $7.71 billion, a price-to-earnings ratio of 13.26 and a beta of 0.87.
Hedge Funds Weigh In On iShares MSCI USA Value Factor ETF
Several large investors have recently bought and sold shares of VLUE. Rothschild Investment LLC purchased a new position in shares of iShares MSCI USA Value Factor ETF during the second quarter worth approximately $26,000. Studio Investment Management LLC purchased a new position in iShares MSCI USA Value Factor ETF during the 3rd quarter worth $28,000. Wilmington Savings Fund Society FSB acquired a new position in iShares MSCI USA Value Factor ETF in the third quarter valued at $29,000. MGB Wealth Management LLC purchased a new stake in shares of iShares MSCI USA Value Factor ETF in the third quarter valued at about $30,000. Finally, Armstrong Advisory Group Inc. purchased a new stake in shares of iShares MSCI USA Value Factor ETF in the third quarter valued at about $30,000.
iShares MSCI USA Value Factor ETF Company Profile
The iShares MSCI USA Value Factor ETF (VLUE) is an exchange-traded fund that is based on the MSCI USA Enhanced Value index. The fund tracks an index of large- and mid-cap US equities. Stocks are selected and weighted using fundamental metrics (earnings, revenue, book value and cash earnings), aiming for exposure to undervalued stocks in each sector.
Featured Articles
- Five stocks we like better than iShares MSCI USA Value Factor ETF
- The 3 Best Retail Stocks to Shop for in August
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Investing In Preferred Stock vs. Common Stock
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- 3 Warren Buffett Stocks to Buy Now
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for iShares MSCI USA Value Factor ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares MSCI USA Value Factor ETF and related companies with MarketBeat.com's FREE daily email newsletter.